BN Business News
Add your company to Business Communicator →

Business · 18/06/1998Updated: 10/17/2026 · 1 min read

FDA Releases Draft Guidance for Topical Dermatological Drug Products

Summary

The FDA is seeking public comments on a new draft guidance that provides recommendations for bioavailability and bioequivalence studies for topically applied dermatological drug products, applicable to NDA and ANDA submissions.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Explore insights

Business insights →